The S&P 500 just marked its longest winning streak since November 2004, closing higher for multiple sessions. U.S. stocks surged on Friday, marking a significant comeback for major indexes, led by a strong jobs report and a possible breakthrough in U.S.-China trade negotiations. The S&P 500 jumped nearly 1.5%, surpassing its April 2 closing level—referred to by President Trump as “Liberation Day,” when sweeping tariffs were announced. The Dow Jones Industrial Average gained 1.4%, logging its ninth consecutive winning day. The tech-focused Nasdaq Composite also climbed roughly 1.5%. Weekly Market Performance: All Major Indexes Climb Friday’s rally capped off a strong week for U.S. equities. The Dow rose 3%, the S&P 500 added nearly 3%, and the Nasdaq outperformed with a 3.4% gain. Optimism over Big Tech earnings and signs of progress in trade discussions were key drivers of the weekly surge. Job Market Beats Expectations Markets were buoyed by a stronger-than-expected U.S. jobs report. Nonfarm payrolls rose by 177,000 in April, exceeding economists’ expectations of 138,000. The unemployment rate remained steady at 4.2%, signaling continued strength in the labor market despite recent volatility tied to tariff fears. Hopes Rise for U.S.-China Trade Talks Investor optimism was further fueled by news from Beijing. China’s commerce ministry indicated openness to talks, saying the "door is open" for negotiations if the U.S. agrees to scale back reciprocal tariffs. This development suggested a possible thaw in trade tensions that had rattled markets since April. Microsoft and Meta Lead the 'Magnificent 7' Among the tech heavyweights, Microsoft MSFT and Meta META stood out last week. Microsoft soared over 11% last week, marking its best performance since March 2023. Meta also posted its strongest week since February 2024. In contrast, Apple lagged behind, falling over 2% for the week following its quarterly results. Apple & Amazon React to Tariff Pressures Despite strong earnings, some tech giants felt the pressure of trade uncertainty. Apple AAPL reported a $900 million tariff headwind this quarter and cut its share buyback program by $10 billion, causing its stock to dip. Amazon AMZN posted solid earnings but offered cautious guidance, citing tariffs and trade policy as key concerns. Its shares ended the day little changed. Winning ETF Areas of the Last Week in Focus Against this backdrop, below we highlight the top-performing exchange-traded fund (ETF) areas of the last week. Story Continues Natural Gas – United States Natural Gas Fund LP UNG – Up 15% U.S. natural gas prices surged last week, thanks to a drop in output and record LNG exports. Production has fallen to a two-month low. Taiwan – iShares MSCI Taiwan ETF EWT – Up 9.7% The outlook for Asian markets is positive. Following gains in U.S. and European markets, Asian markets also gained. Cues of trade de-escalation have also acted positively for the Taiwan market. Cryptocurrency – First Trust SkyBridge Crypto Industry & Digital Economy ETF CRPT – Up 7.5% Bitcoin gained 1.6% last week on the comeback of the risk-on trade sentiment. This benefited the cryptocurrency stocks overall. Uranium Miners – Sprott Junior Uranium Miners ETF URNJ – Up 6.9% The uranium demand is on the rise as AI-driven data centers fuel greater power needs. The World Nuclear Association, as quoted on Oilprice.com, projects reactor demand to increase 28% by 2030 and nearly double by 2040. Some Big Tech earnings released last week revealed that their capex on AI remains on track, which boosted the URNJ ETF (read: Is This the Perfect Time to Invest in Uranium ETFs?). Pharma – Roundhill GLP-1 & Weight Loss ETF OZEM – Up 6.4% Novo Nordisk NVO said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid an intense race to get an oral weight-loss medication on the market. If approved, Wegovy would become the first oral formulation of a GLP-1 drug for chronic weight management. The NVO stock, which surged 11.4% last week, makes up about 12% of the fund OZEM. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amazon.com, Inc. (AMZN):Free Stock Analysis Report Apple Inc. (AAPL):Free Stock Analysis Report Microsoft Corporation (MSFT):Free Stock Analysis Report Novo Nordisk A/S (NVO):Free Stock Analysis Report iShares MSCI Taiwan ETF (EWT): ETF Research Reports United States Natural Gas ETF (UNG): ETF Research Reports Meta Platforms, Inc. (META):Free Stock Analysis Report First Trust SkyBridge Crypto Industry and Digital Economy ETF (CRPT): ETF Research Reports Sprott Junior Uranium Miners ETF (URNJ): ETF Research Reports Roundhill GLP-1 & Weight Loss ETF (OZEM): ETF Research Reports This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Inside Last Week's Wall Street Rally & Best-Performing ETF Areas
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...